Heramed Ltd · ASX:HMD
Heramed — Investor Presentation (February 2026)
26 slides from Heramed's investor presentation, Feb 26, 2026
Slide 1: Investor Presentation February 2026
For personal use only Investor Presentation February 2026 A leader in AI-powered women’s health solution spanning pregnancy to chronic care with a proprietary FDA-cleared device
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by HeraMED Limited ('HMD’) ABN 65 626 295 314. All information contained in this presentation (including this notice) ('Information') is confidential. By receiving the forward-looking you are deemed to agree that For personal use only you will hold the
Slide 3: The US Maternity Problem
The US Maternity Problem For personal use only 84% 10.4% of US pregnancy related of US births are The US has over 2× deaths are preventable3 preterm4 the maternal mortality rate of developed nations¹ ~60,000 1-in-4 U.S women face life- US women receive threatening inadequate care complications annua
Slide 4: HeraMED's Solution
HeraMED’s Solution For personal use only Enterprise grade platform for Healthcare providers enabling continuous digital monitoring Hera across maternity & women’s health ✓ Remote monitoring of maternal and fetal health using connected medical devices CARE ✓ Continuous clinical visibility by the heal
Slide 5: HeraMED: Corporate Snapshot
HeraMED: Corporate Snapshot HeraMED is a global medical data & technology company leading the digital transformation of women’s care For personal use only 12 Month Share Price Chart Board of Directors Share Price Volume (A$/Sh) (M) Tim Chapman Chairman 0.05 20 18 Anoushka Gungadin CEO & Managing Dir
Slide 6: HeraMED Healthcare Veterans
HeraMED Healthcare Veterans HeraMED has transformed its teams to deliver upon its global commercialisation initiatives Anoushka Gungadin Cameron Jones Jeff Garibaldi Mandy Khaira, MD, MPH Vivek Krishnan Nicole Zappala CEO & Managing Director CFO & Co Secretary Chief Growth Officer Chief Clinical Tra
Slide 7: Investment Highlights
Investment Highlights HeraMED best-in-class digital health platform, HeraCARE is transforming maternity and women’s care For personal use only HeraCARE: A Scalable HeraCARE is a proprietary digital platform purpose-built for maternity and postpartum Women’s Health Platform care, expanding across the
Slide 8: Challenges in Maternity Care
Challenges in Maternity Care The maternity care in the US is worsening Challenges Outcomes For personal use only Century-old Model of care Maternity care is delivered using an outdated model, with limited appointments & monitoring 1 in 4 Women in US Access/inequity of care DO NOT see a physician in
Slide 9: US Maternity Crisis – Millions Left without Care
US Maternity Crisis – Millions Left without Care 36% of the US is a maternity desert with no clinic: HeraMED is the solution to this critical issue For personal use only $111B spent on $7.5B for hypertensive maternity care annually1 disorders annually4 500+ hospitals closed $18.1B for maternal mater
Slide 10: Structural gaps in maternal care & monitoring
Structural gaps in maternal care & monitoring Limited provider access and lack of postpartum oversight drive preventable complications and mortality For personal use only Access to OB-GYNs & Midwives1 Occurrence of Pregnancy related deaths1 CHL 12 80 92 Pregnancy Delivery/Birth After birth (postpart
Slide 11: HeraCARE: Mother's Perspective
HeraCARE Mother’s Telehealth Visits AI Virtual Companion Perspective seamlessly launch alongside patient data and patient-facing app For personal use only 1. Pregnancy Monitoring HeraCARE AI-powered insights Women’s Care Designer within clinician • Remote vital signs monitoring & for evidence-based
Slide 12: HeraCARE: Healthcare Provider's Perspective
HeraCARE Healthcare Provider’s For personal use only Perspective 1. Continuous Remote Monitoring • Real-time visibility • Early identification of high-risk pregnancies 2. Decision Support • Automated risk detection • Evidence-based care plans 3. Seamless Integration • Unified patient dashboard • Sim
Slide 13: Delivering Efficient & Effective Care
Delivering Efficient & Effective Care From episodic appointments to continuous, clinically-guided maternity care For personal use only >50% fewer in-person visits Customised care plans Detects complications early Ongoing postpartum support enabled by virtual care and Personalised & clinically such a
Slide 14: HeraCARE - Outstanding Early Data
HeraCARE - Outstanding Early Data HeraMED addresses the challenges with a Next Gen, AI-Powered Solution Designed for Scale Clinical Outcomes Patient Data For personal use only Boosts clinician Identifies hypertension productivity by up to earlier by week 94% 46% 25 Patient satisfaction result Face-t
Slide 15: HeraMED Revenue Generating Model
HeraMED Revenue Generating Model Multiple revenue streams per health system US$50 For personal use only High-margin platform Recurring Platform subscription revenue that Revenue scales with patient volumes per mum / per month + Device & Devices, deployment, integration, and configuration Implementat
Slide 16: Key Figures: Market & HeraCARE Economics
Key Figures: Market & HeraCARE Economics HeraCARE improves outcomes, drives revenues, and delivers measurable savings and efficiencies Indicative Hospital For personal use only Low (US$) High (US$) 3.6m births Economics1 (per pregnancy) Traditional Pregnancy Revenue2 $5,500 $7,500 per year in the U.
Slide 17: Funding & Grants Supporting Digital Health
Funding & Grants Supporting Digital Health Government, federal, and health system funding accelerating adoption of remote monitoring and virtual care For personal use only Structural Funding Drivers U.S. healthcare system under pressure, accelerating funding for scalable digital and remote care solu
Slide 18: Go to Market Strategy
Go to Market Strategy Health Systems & Hospitals Payers & Insurers Public / Grant-Funded Health Programs For personal use only Broader Commercialisation Scale & Expand Offering Staged • Roll out across health system Rollout networks • Use reference sites to accelerate Scale Deployment adoption Pilot
Slide 19: Commercialisation: Lee Health Rollout
Commercialisation: Lee Health Rollout For personal use only Lee Health is a major US not-for-profit health system in Florida operating care hospitals, a children’s hospital and a network of medical facilities supported by more than 1,100 physicians. • Initial Clinical pilot of HeraCARE for 3-6 month
Slide 20: Commercialisation: Philips Partnership
Commercialisation: Philips Partnership For personal use only Telcare Medical Supply LLC is a US-based subsidiary of Philips (NYSE:PHG), a global health technology leader operating established healthcare infrastructure and distribution capabilities to support large-scale clinical deployment. • Commer
Slide 21: Partnership: Garmin
Partnership: Garmin For personal use only Garmin (NYSE: GRMN) is a global leader in smartwatches and GPS-enabled products, with its Garmin Health division delivering digital health solutions powered by data from its wearable ecosystem. • Strategic collaboration to integrate Garmin smartwatch data in
Slide 22: Digital Women's Health Platforms
Digital Women’s Health Platforms Level 1 Level 2 Level 3 Level 4 Remote Maternity- AI-Enabled Digital Women’s Patient Specific Enterprise Women’s For personal use only Health Platform Monitoring Solutions Health Platform Most providers focus on specific components of Key Providers women’s health Vit
Slide 23: The Future: Fertility to Chronic Care Management
The Future Fertility to Chronic Care Management For personal use only HeraMED aims to deliver the worlds first end-to-end women’s health management platform On a mission to serve Women-centered across women’s health intelligent platform 23
Slide 24: HeraMED Development Timeline
HeraMED Development Timeline Building momentum: validated platform, strengthened leadership, and early commercial traction For personal use only HeraBEAT regulatory approvals Corporate strategy reset and Targeting major U.S. customer and commercial launch leadership transformation partnerships and p
Slide 25: 2026 Pivotal Milestones
2026 Pivotal Milestones For personal use only 0-6 Months 6-12 Months Prepare for Commercial Scale Scale Commercial Deployment Converting Pilots into Hospital Deployments Scaling health system adoption o Progress hospital commercial model in partnership o Expand Lee Health into Phase 2, increasing pa
Slide 26: Backup Section
For personal use only Backup Section Anoushka Gungadin - CEO & Managing Director anoushka@hera-med.com 26